-
3 questions as GAVI approaches next replenishment
The GAVI Alliance is gearing up for a new replenishment, in which the organization plans to ask for more funds than it ever has before.
- Categories
- Health Care
-
Health risk: DHO short of typhoid vaccine since 11 months
For the residents of the provincial capital, heading to roadside stalls for a cold drink or quick bite will not be such a good idea this summer, especially if they have not had a shot of the typhoid vaccine. And given the current shortage of said vaccines, most Peshawarites are probably already at risk for contracting this debilitating disease.
- Categories
- Health Care
-
Gavi Alliance to Present Plans to Expand Impact of Vaccines By 2020 in Africa
Drive to secure a healthy future for children in developing countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Ebola deaths rise to 135 as vaccine research lags
As the death toll from the Ebola virus in West Africa climbs to 135 people, a vaccine to combat the deadly virus remains years out of reach.
- Categories
- Health Care
-
Immunization Support Expiring for Some: GAVI, partners aim to help countries achieve successful ‘graduation’
The GAVI Alliance has helped some of the world’s poorest countries immunize their children. Soon, several of these countries are scheduled to "graduate" from this support. These countries will face a variety of challenges, but they’re already getting help planning for the transition.
- Categories
- Environment, Health Care
- Tags
- governance, infrastructure, vaccines
-
Fears for global health R&D after US budget battle
Future research and development targeting diseases such as HIV, tuberculosis and malaria may be at risk because of across-the-board federal cuts implemented last year by the United States, the largest funder of global health R&D, warns a report.
- Categories
- Education, Health Care
-
Balancing Profits Against Public Health in the Search for Innovative Vaccines
There is no cure and no vaccine for the Ebola virus, which has killed about 70 people in Guinea. Vaccine expert Professor Adrian Hill tells DW why some vaccines take time. It's got to do with profit.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
US Global Health Research Funding Falls Short of Innovation Rhetoric
Despite the Obama administration's emphasis on science, technology, and innovation for international development, United States funding for global health research and development is not what it could or should be, according to an advocacy coalition of 30 global health nongovernmental organizations
- Categories
- Health Care
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.